ATP5MG - New-wiki

Novel	Interactant Symbol	Name	Associated Pathways Hide	Binding Drugs Hide	Associated Diseases Hide
Novel	C2CD2L	C2CD2 like
Novel	CEP164	centrosomal protein 164	Regulation of PLK1 Activity at G2/M Transition Loss of Nlp from mitotic centrosomes Recruitment of mitotic centrosome proteins and complexes Loss of proteins required for interphase microtubule organization from the centrosome Recruitment of NuMA to mitotic centrosomes Anchoring of the basal body to the plasma membrane AURKA Activation by TPX2
Novel	GCKR	glucokinase regulator	Regulation of Glucokinase by Glucokinase Regulatory Protein Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC)
Novel	PARD6A	par-6 family cell polarity regulator alpha	TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) Tight junction interactions Asymmetric localization of PCP proteins
Novel	PLEKHA4	pleckstrin homology domain containing A4	Synthesis of PIPs at the plasma membrane	Inositol 1,3,4,5-Tetrakisphosphate
Novel	PPP1CA	protein phosphatase 1 catalytic subunit alpha	Triglyceride catabolism DARPP-32 events Downregulation of TGF-beta receptor signaling Circadian Clock	2,6,8-Trimethyl-3-Amino-9-Benzyl-9-Methoxynonanoic Acid
Novel	SIK3	SIK family kinase 3		Fostamatinib
Novel	SLC4A1AP	solute carrier family 4 member 1 adaptor protein
Novel	SRD5A2	steroid 5 alpha-reductase 2	Androgen biosynthesis	Spironolactone Azelaic acid Dutasteride Finasteride	46,XY disorders of sex development (Disorders in androgen synthesis or action), including: Congenital adrenal hyperplasias; Leydig cell hypoplasia; Androgen insensitivity syndrome (AIS)
	MAGEC1	MAGE family member C1
	RHOU	ras homolog family member U	Rho GTPase cycle Interleukin-4 and Interleukin-13 signaling

Search Results for: ATP5MG